This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Competent Cells Market

Are Competent Cells the Future of Human Cloning in the Medical Industry? Explore More in FMI’s Latest Insights!

Competent Cells Market by Product, Application, End User & Region - Forecast for 2022 – 2032

Competent Cells Market Outlook-2022-2032

[276 Pages Report] The global competent cells market is expected to reach US$ 2.1 Bn by the end of 2022, registering double-digit growth at 11.1% CAGR during the forecast period (2022-2032). Sales in the market are expected to reach a valuation of ~US$ 5.9 Bn by 2032. In terms of product type, the chemically competent cells led the market with a share of about 67.8% in 2021.

Competent cells are bacterial cells which can utilise foreign DNA from their surroundings through a process known as transformation. Griffith described it initially in Streptococcus pneumoniae. If the cell walls of E. coli are changed, the cells tend to absorb the DNA. Calcium chloride and temperature shock therapy can make the cells competent. Rapidly growing cells can be rendered more competent than cells at other phases of development.

Attributes

Key Insights

Competent Cells Market Value 2021

US$ 1.9 Bn

Estimated Market Size 2022

US$ 2.1 Bn

Projected Market Value 2032

US$ 5.9 Bn

CAGR 2022-2032

11.1%

Market Share of Top 5 Countries

57.4%

Customize this Report

Let us know your requirement to get
100% FREE customization

Cloning Applications to open up New Avenues during the Forecast Period

Cloning is expected to expand significantly in the application area due to the growing demand for molecularly cloned items. The cloning sector has benefited from COVID-19 as a result of corporations investing more money in research and development. Furthermore, it is anticipated that the segment would develop faster because of increased cloning research and financial assistance from a number of organizations.

Techniques for cell engineering, such as somatic cell nuclear transfer (SCNT), have demonstrated a variety of uses, including the creation of transgenic animals, the preservation of endangered species, and therapeutic cloning. Since competent cells may be employed in therapeutic cloning research, these fields are anticipated to experience renewed attention, which will lead to an increase in demand for these cells.

Due to rising R&D expenditures and the commercialization of proteomics and genomics-based goods, the biotechnology sector is also anticipated to see a significant growth rate. The need for cutting-edge product advancements in the treatment of different ailments is also anticipated to support the segment's expansion. Additionally, it is projected that increased investment for research into DNA cloning methods at academic research facilities and the usage of these products in therapies will accelerate market growth in the near future.

Competent Cells Market Download Report Brochure

APAC to bring in more demand during 2022-2032

During the projected period, it is predicted that the Asia-Pacific market would account for a large portion of the worldwide competent cells market. Extensive research on DNA cloning methods in the area and the existence of significant market participants are credited with the expansion. For instance, Takara Bio Inc. stated in January 2021 that its new facility, the Center for Gene and Cell Processing II, for manufacturing and research purposes, had been completed in Shiga, Japan.

China is expected to develop at a profitable CAGR of 10.1% throughout the projected period and will hold a market share of around 54.2% in East Asia in 2021. The competent cells market will grow as research funding and activity increase. For instance, the State Key Laboratory of Microbial Application, the Natural Science Foundation of China, and SDU's Qilu Youth Scholar Startup Funding all provided funding for a research study on Escherichia coli BW25113 competent cells made using a straightforward chemical method that has unparalleled transformation and cloning efficiencies in 2022.

Another regional company, HiMedia Solutions, is situated in India and produces a wide range of goods for the market for competent cells. The HiPurA BL21(DE3) Competent Cells, Bacterial Transformation Kit, HiPurA XL1-Blue Competent Cells and HiPurA Competent Cells are its four main items for this market. The business is India's top producer of trustworthy cells. Its goods made cloning experiments simpler, such as the HiPurA Competent Cells, which were the first competent DH5a cells marketed on the Indian market. The existence of such businesses is probably going to benefit market growth.

Competent cells are bacterial cells, which can utilise foreign DNA from their surroundings through a process known as transformation. Griffith described it initially in Streptococcus pneumoniae. If the cell walls of E.coli are changed, the cells have a greater tendency to absorb the DNA. Calcium chloride and temperature shock therapy can make the cells competent. Rapidly growing cells can be rendered more competent than cells at other phases of development. Following transformation, the cells may express the acquired genetic information.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Sales Analysis of Competent Cells Market from 2017 to 2021 Vs Demand Outlook for 2022 to 2032

As per Future Market Insights (FMI), the competent cells market was approximately 12.8% of the overall ~US$ 14.5 Bn global cell expansion market in 2021. Overall sales of competent cells expanded at a CAGR of 9.9% from 2017 to 2021, on the back of rising expansion of healthcare industry.

Increasing adoption of molecular cloned products, recombinant proteins, advancement in molecular cloning research and development with the emergence of new technologies, and numerous government initiatives and government grants available for life science research are the key factors driving industry growth during the forecast period.

Furthermore, Gene therapy can potentially treat a wide range of ailments. Increasing prevalence of cancer, cardiovascular diseases, cystic fibrosis, blood disorders and immunocompromised cases is rising, which will boost the market in the forecast period. Gene therapy attempts to cure an ailment or enhance your body's capacity to fight disease by replacing a malfunctioning gene or introducing a new gene.

According to World Health Organization (WHO) 2022, cancer is the largest cause of mortality around the globe, accounting for over 10 million deaths in 2020, or roughly one in every six. Colon, lung, breast, rectum, and prostate cancers are the most prevalent. Tobacco use, obesity, alcohol consumption, a lack of consumption of fruits and vegetables, and an insufficient level of physical activity account for almost one-third of cancer fatalities.

In addition, cystic fibrosis is a widespread hereditary condition throughout the white population in the United States. The condition affects one in every 2,500 to 3,500 white babies. Cystic fibrosis affects around one in every 17,000 African Americans and 31,000 Asian Americans, as stated by MedlinePlus in 2021. These conditions require gene therapy, which will positively impact the competent cells market. Backed by these aforementioned factors, the global competent cells market is expected to grow at a CAGR of 11.1% during the forecast period.

What are the Key Opportunities for the Competent Cells Market Manufacturers?

  • Favorable Government Initiatives for Gene Therapy Products to Push the Sales

Growth in the market is predicted to surge on the back of favourable initiatives by governments in emerging countries, increasing FDA approval for gene therapy products, and advancements in research and developmental activities. These factors will boost the demand for better technologies, creating conducive environment in the competent cells market.

Recombinant DNA technology is one of the most commonly used techniques in introducing a specific gene or a healthy gene into a vector. These vectors can be plasmodial, viral or nanostructured; the latter is the most commonly used because of its efficacy in colonising cells and incorporating their genetic material.

Moreover, recent advances in recombinant DNA synthesis have enabled the effective production of recombinant proteins at industrial sizes with higher yields and lower production costs. This has enabled the development of new treatments, vaccines, and diagnostic reagents.

Certain nutrients are allowed to clone human genes, which reduces the likelihood of unfavourable immune system reactions in patients, allows for the creation of highly specialised, functional, and active proteins, increases productivity and cost-effectiveness, and reduces the possibility of unknown pathogen transmission from animals or humans.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

What are the Factors Restraining the Demand for Competent Cells?

Rising cost of research and developmental activities and stringent regulations in the field might hamper the growth in the forecast period. Competent cells are utilised in molecular cloning procedures, protein expression, and various plasmid DNA-based applications.

However, depending on the transformation method, for instance, developing the E. coli competent cells can be time-consuming, needing exceptionally pure water, high-grade reagents, specified autoclaved glassware, and or even specialised equipment (electroporators).

Numerous protocols available describe the technique and buffers needed to produce competent cells. There are even kits available that include pre-made buffers to expedite this process. Furthermore, it is more expensive to use electroporation.

A specialised apparatus is required to implement the charge, in addition to cuvettes to transport the charge to the cell solution. Excess salt in the cuvette can cause electroporation to fail and result in the loss of valuable samples. The most widely mentioned disadvantage of chemical transformation is its reduced efficiency.

Country-wise Insights

What Makes the U.S. a Lucrative Competent Cells Market?

Growing Investment in Gene Cell Therapy Products to Boost the Demand

The U.S. dominated the North America competent cells market and accounted for nearly 84.8% in 2021. Demand in the market is anticipated to surge on the back of rising investment in gene therapy products. Further, increasing research and development by government bodies, grants and clinical trials for disease treatment and others, will improve the growth of the competent cells market.

Will China Retain its Dominance in the East Asia Competent Cells Market?

China Competent Cells Market to Benefit from Rising Research & Development for Cloning Efficiency

China held approximately 54.2% share in the East Asia competent cells market in 2021. Demand for competent cells in China will rise at a CAGR of 10.1% during the forecast period. Increasing research activities and grants will propel the competent cells market.

For instance, the Natural Science Foundation of China, the funding by the State Key Laboratory of Microbial Application, and Qilu Youth Scholar Startup Funding of SDU, funded research study on Escherichia coli BW25113 competent cells prepared using a simple chemical method having unmatched transformation and cloning efficiencies, in 2022.

What is the Demand Outlook in Germany Competent Cells Market?

Introduction of Different Strains for Gene Transformation to Propel Sales

As per FMI, the overall sales in the Germany competent cells market are projected to expand at 9.3% CAGR in the Europe competent cells market during the forecast period. Increasing production activities by manufacturers to develop different types of strains, which allows easy gene transformation, will propel the market. For instance, New England Biolabs GmbH has products specific to cloning & subcloning and strains for protein expression, with each type having quality specifications.

Category-wise Insights

Which Competent Cells Product is Driving Market Growth?

Nearly 7 out of 10 Sales to be Contributed by Chemically Competenet Cells

Chemically competent cells are expected to present high growth at a CAGR of 15.3% between 2022 and 2032, with a share of about 67.8% in 2021. Cloning, DNA sequencing, and the creation of DNA libraries are just a few of the many molecular biology techniques that frequently include transformation. Competent cells must be used to perform the transformation. Chemically competent cells hold a bigger market share because chemical transformation is quicker and less error-prone than electroporation.

Which is the Chief Application in Competent Cells Market?

Cloning Segment to Account for Around 3/5th of Competent Cells Sales

In terms of application, the cloning segment held a revenue share of 57.8% in 2021 and is expected to display steady growth over the forecast period. Competent cells are frequently employed in molecular cloning to increase and preserve cloned DNA in plasmids because they are engineered to absorb foreign DNA from the environment more efficiently. With growing investments in cell and gene therapy, the cloning segment holds a higher market share in terms of application within the overall competent cells market, globally.

Based on end user, the academic research institutes held the highest market share value of 51.2% in 2021. Increasing research and development activities in life sciences are propelling sales of the overall competent cells market.

Competitive Landscape

With several competitors in the competent cells market, the overall market is fragmented. To expand their customer base, leading companies are implementing methods such as mergers and acquisitions, partnerships and collaborations, and new product launches.

For instance:

  • The VmaxTM X2 Competent Cells were introduced in January 2020 by SGI-DNA, the company behind the BioXpTM 3200 System and Gibson Assembly® Reagents. They are intended to produce two to four times as much soluble protein in half the time as current methods that rely on E. coli.
  • Bluebird Bio announced the introduction of ZYNTEGLOTM Gene Therapy for Patients with Transfusion-Dependent -Thalassemia Who Do Not Have β?/β0 Genotype in Germany in January 2020.

Report Scope as per Competent Cells Industry Analysis

Attribute

Details

Estimated Market Size 2022

US$ 2.1 Bn

Projected Market Value 2032

US$ 5.9 Bn

CAGR 2022-2032

11.1%

Forecast Period

2017-2021

Historical Data Available for

2022-2032

Market Analysis

US$ Mn for Value

Key Regions Covered

North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa

Key Countries Covered

U.S., Canada, Brazil, Mexico, Argentina, U.K., Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC, South Africa and North Africa

Key Market Segments Covered

Product, Application, End User, and Region

Key Companies Profiled

  • Agilent Technologies Inc.
  • Genescript Biotech Corporation
  • Bio-Rad Laboratories Inc
  • Merck & Co Inc
  • OriGene Technologies, Inc
  • New England Biolabs Inc
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.,
  • QIAGEN N.V.,
  • Zymo Research Corporation
  • Promega Corporation
  • HiMedia Laboratories
  • Avantor, Inc.
  • Scarab Genomics, LLC
  • Lucigen
  • bluebird bio, Inc.
  • Tonbo Biosciences
  • Transgen Biotech
  • Codex DNA, Inc.

Key Market Segments Covered in Competent Cells Industry Research

By Product:

  • Chemically Competent Cells
  • Electrocompetent Cells

By Application:

  • Cloning
  • Protein Expression
  • Other Applications

By End User:

  • Academic Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Frequently Asked Questions

The global competent cells market is worth US$ 1.9 Bn in 2021 and is set to expand by 2.9X over the next ten years.

The competent cells market is expected to reach US$ 5.9 Bn by the end of 2032, with sales revenue expected to register an 11.1% CAGR.

The growing prevalence of genetic disorders and increasing research and developments are some of the key trends in this market.

The U.S., India, China, Germany, and Japan are expected to drive demand for the competent cells industry.

North America is expected to lead the growth in competent cells market, with the U.S. accounting for about 84.8% of the share in 2021.

Demand for competent cells in Europe is expected to register a growth of 10.9% over the next ten years.

Demand for competent cells in Latin America is expected to register a growth at 10.6% CAGR over the next ten years

Demand for competent cells in MEA is expected to register a growth of 8.7% over the next ten years

China, the U.S., and Germany are the key producers of competent cells.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Technology Roadmap

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Key Success Factors

    4.1. Disease Epidemiology

    4.2. Cost Structure

    4.3. Regulatory Scenario

    4.4. Reimbursement Landscape

    4.5. PESTEL analysis

    4.6. Porter’s analysis

    4.7. Supply Chain

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare GDP Growth Overview

        5.1.3. Global Cell Expansion Market Overview

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Rising prevalence of Chronic Diseases

        5.2.2. Increasing Awareness and Adoption

        5.2.3. New Product Launches

        5.2.4. Growing R&D for Competent Cells

        5.2.5. Growing Investments for Molecular Cloning Research

        5.2.6. Growing Commercial Demand for Molecular Cloned Products

    5.3. Value Chain

        5.3.1. Raw Material Suppliers

        5.3.2. Product Manufacturers

        5.3.3. End Users

    5.4. Market Dynamics

        5.4.1. Drivers

        5.4.2. Restraints

        5.4.3. Opportunity Analysis

    5.5. Global Supply Demand Analysis

6. COVID-19 Crisis – Crisis Analysis

    6.1. COVID-19 and Impact Analysis

        6.1.1. By Product

        6.1.2. By Application

        6.1.3. By End User

        6.1.4. By Region

    6.2. 2021 Market Scenario

7. Global Market Demand (in Value or Size in US$ Mn) Analysis 2017-2021 and Forecast, 2022–2032

    7.1. Historical Market Value (US$ Mn) Analysis, 2017-2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2017-2021 and Forecast 2022–2032, by Product

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Product , 2017-2021

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product , 2022–2032

        8.3.1. Chemically Competent Cells

        8.3.2. Electrocompetent Cells

    8.4. Market Attractiveness Analysis By Product

9. Global Market Analysis 2017-2021 and Forecast 2022–2032, by Application

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By Application, 2017-2021

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022–2032

        9.3.1. Cloning

        9.3.2. Protein Expression

        9.3.3. Other Applications

    9.4. Market Attractiveness Analysis By Application

10. Global Market Analysis 2017-2021 and Forecast 2022–2032, by End User

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis, By End User, 2017-2021

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022–2032

        10.3.1. Academic Research Institutes

        10.3.2. Pharmaceutical & Biotechnology Companies

        10.3.3. Contract Research Organizations

    10.4. Market Attractiveness Analysis By End User

11. Global Market Analysis 2017-2021 and Forecast 2022–2032, by Region

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Analysis By Region, 2017-2021

    11.3. Current Market and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022–2032

        11.3.1. North America

        11.3.2. Latin America

        11.3.3. Europe

        11.3.4. East Asia

        11.3.5. South Asia

        11.3.6. Oceania

        11.3.7. Middle East and Africa (MEA)

    11.4. Market Attractiveness Analysis By Region

12. North America Market Analysis 2017-2021 and Forecast 2022–2032

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2021

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032

        12.3.1. By Country

            12.3.1.1. U.S.

            12.3.1.2. Canada

        12.3.2. By Product

        12.3.3. By Application

        12.3.4. By End User

    12.4. Market Attractiveness Analysis

        12.4.1. By Country

        12.4.2. By Product

        12.4.3. By Application

        12.4.4. By End User

    12.5. Market Trends

    12.6. Key Market Participants - Intensity Mapping

    12.7. Drivers and Restraints - Impact Analysis

    12.8. Country Level Analysis & Forecast

        12.8.1. U.S. Market Analysis

            12.8.1.1. .Introduction

            12.8.1.2. Market Analysis and Forecast by Market Taxonomy

                12.8.1.2.1. By Product

                12.8.1.2.2. By Application

                12.8.1.2.3. By End User

        12.8.2. Canada Market Analysis

            12.8.2.1. Introduction

            12.8.2.2. Market Analysis and Forecast by Market Taxonomy

                12.8.2.2.1. By Product

                12.8.2.2.2. By Application

                12.8.2.2.3. By End User

13. Latin America Market Analysis 2017-2021 and Forecast 2022–2032

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2021

    13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032

        13.3.1. By Country

            13.3.1.1. Mexico

            13.3.1.2. Brazil

            13.3.1.3. Argentina

            13.3.1.4. Rest of Latin America

        13.3.2. By Product

        13.3.3. By Application

        13.3.4. By End User

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Product

        13.4.3. By Application

        13.4.4. By End User

    13.5. Market Trends

    13.6. Key Market Participants - Intensity Mapping

    13.7. Drivers and Restraints - Impact Analysis

    13.8. Country Level Analysis & Forecast

        13.8.1. Mexico Market Analysis

            13.8.1.1. Introduction

            13.8.1.2. Market Analysis and Forecast by Market Taxonomy

                13.8.1.2.1. By Product

                13.8.1.2.2. By Application

                13.8.1.2.3. By End User

        13.8.2. Brazil Market Analysis

            13.8.2.1. Introduction

            13.8.2.2. Market Analysis and Forecast by Market Taxonomy

                13.8.2.2.1. By Product

                13.8.2.2.2. By Application

                13.8.2.2.3. By End User

        13.8.3. Argentina Market Analysis

            13.8.3.1. Introduction

            13.8.3.2. Market Analysis and Forecast by Market Taxonomy

                13.8.3.2.1. By Product

                13.8.3.2.2. By Application

                13.8.3.2.3. By End User

14. Europe Market Analysis 2017-2021 and Forecast 2022–2032

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2021

    14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032

        14.3.1. By Country

            14.3.1.1. Germany

            14.3.1.2. Italy

            14.3.1.3. France

            14.3.1.4. U.K.

            14.3.1.5. Spain

            14.3.1.6. BENELUX

            14.3.1.7. Russia

            14.3.1.8. Rest of Europe

        14.3.2. By Product

        14.3.3. By Application

        14.3.4. By End User

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Product

        14.4.3. By Application

        14.4.4. By End User

    14.5. Market Trends

    14.6. Key Market Participants - Intensity Mapping

    14.7. Drivers and Restraints - Impact Analysis

    14.8. Country Level Analysis & Forecast

        14.8.1. Germany Market Analysis

            14.8.1.1. Introduction

            14.8.1.2. Market Analysis and Forecast by Market Taxonomy

                14.8.1.2.1. By Product

                14.8.1.2.2. By Application

                14.8.1.2.3. By End User

        14.8.2. Italy Market Analysis

            14.8.2.1. Introduction

            14.8.2.2. Market Analysis and Forecast by Market Taxonomy

                14.8.2.2.1. By Product

                14.8.2.2.2. By Application

                14.8.2.2.3. By End User

        14.8.3. France Market Analysis

            14.8.3.1. Introduction

            14.8.3.2. Market Analysis and Forecast by Market Taxonomy

                14.8.3.2.1. By Product

                14.8.3.2.2. By Application

                14.8.3.2.3. By End User

        14.8.4. U.K. Market Analysis

            14.8.4.1. Introduction

            14.8.4.2. Market Analysis and Forecast by Market Taxonomy

                14.8.4.2.1. By Product

                14.8.4.2.2. By Application

                14.8.4.2.3. By End User

        14.8.5. Spain Market Analysis

            14.8.5.1. Introduction

            14.8.5.2. Market Analysis and Forecast by Market Taxonomy

                14.8.5.2.1. By Product

                14.8.5.2.2. By Application

                14.8.5.2.3. By End User

        14.8.6. BENELUX Market Analysis

            14.8.6.1. Introduction

            14.8.6.2. Market Analysis and Forecast by Market Taxonomy

                14.8.6.2.1. By Product

                14.8.6.2.2. By Application

                14.8.6.2.3. By End User

        14.8.7. Russia Market Analysis

            14.8.7.1. Introduction

            14.8.7.2. Market Analysis and Forecast by Market Taxonomy

                14.8.7.2.1. By Product

                14.8.7.2.2. By Application

                14.8.7.2.3. By End User

15. South Asia Market Analysis 2017-2021 and Forecast 2022–2032

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2021

    15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032

        15.3.1. By Country

            15.3.1.1. India

            15.3.1.2. Indonesia

            15.3.1.3. Malaysia

            15.3.1.4. Thailand

            15.3.1.5. Rest of South Asia

        15.3.2. By Product

        15.3.3. By Application

        15.3.4. By End User

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Product

        15.4.3. By Application

        15.4.4. By End User

    15.5. Market Trends

    15.6. Key Market Participants - Intensity Mapping

    15.7. Drivers and Restraints - Impact Analysis

    15.8. Country Level Analysis & Forecast

        15.8.1. India Market Analysis

            15.8.1.1. Introduction

            15.8.1.2. Market Analysis and Forecast by Market Taxonomy

                15.8.1.2.1. By Product

                15.8.1.2.2. By Application

                15.8.1.2.3. By End User

        15.8.2. Indonesia Market Analysis

            15.8.2.1. Introduction

            15.8.2.2. Market Analysis and Forecast by Market Taxonomy

                15.8.2.2.1. By Product

                15.8.2.2.2. By Application

                15.8.2.2.3. By End User

        15.8.3. Malaysia Market Analysis

            15.8.3.1. Introduction

            15.8.3.2. Market Analysis and Forecast by Market Taxonomy

                15.8.3.2.1. By Product

                15.8.3.2.2. By Application

                15.8.3.2.3. By End User

        15.8.4. Thailand Market Analysis

            15.8.4.1. Introduction

            15.8.4.2. Market Analysis and Forecast by Market Taxonomy

                15.8.4.2.1. By Product

                15.8.4.2.2. By Application

                15.8.4.2.3. By End User

16. East Asia Market Analysis 2017-2021 and Forecast 2022–2032

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2021

    16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032

        16.3.1. By Country

            16.3.1.1. China

            16.3.1.2. Japan

            16.3.1.3. South Korea

        16.3.2. By Product

        16.3.3. By Application

        16.3.4. By End User

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Product

        16.4.3. By Application

        16.4.4. By End User

    16.5. Market Trends

    16.6. Key Market Participants - Intensity Mapping

    16.7. Drivers and Restraints - Impact Analysis

    16.8. Country Level Analysis & Forecast

        16.8.1. China Market Analysis

            16.8.1.1. Introduction

            16.8.1.2. Market Analysis and Forecast by Market Taxonomy

                16.8.1.2.1. By Product

                16.8.1.2.2. By Application

                16.8.1.2.3. By End User

        16.8.2. Japan Market Analysis

            16.8.2.1. Introduction

            16.8.2.2. Market Analysis and Forecast by Market Taxonomy

                16.8.2.2.1. By Product

                16.8.2.2.2. By Application

                16.8.2.2.3. By End User

        16.8.3. South Korea Market Analysis

            16.8.3.1. Introduction

            16.8.3.2. Market Analysis and Forecast by Market Taxonomy

                16.8.3.2.1. By Product

                16.8.3.2.2. By Application

                16.8.3.2.3. By End User

17. Oceania Market 2017-2021 and Forecast 2022-2032

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2021

    17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032

        17.3.1. By Country

            17.3.1.1. Australia

            17.3.1.2. New Zealand

        17.3.2. By Product

        17.3.3. By Application

        17.3.4. By End User

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Product

        17.4.3. By Application

        17.4.4. By End User

    17.5. Key Market Participants - Intensity Mapping

    17.6. Drivers and Restraints - Impact Analysis

    17.7. Country Level Analysis & Forecast

        17.7.1. Australia Market Analysis

            17.7.1.1. Introduction

            17.7.1.2. Market Analysis and Forecast by Market Taxonomy

                17.7.1.2.1. By Product

                17.7.1.2.2. By Application

                17.7.1.2.3. By End User

        17.7.2. New Zealand Market Analysis

            17.7.2.1. Introduction

            17.7.2.2. Market Analysis and Forecast by Market Taxonomy

                17.7.2.2.1. By Product

                17.7.2.2.2. By Application

                17.7.2.2.3. By End User

18. Middle East and Africa (MEA) Market Analysis 2017-2021 and Forecast 2022–2032

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2021

    18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032

        18.3.1. By Country

            18.3.1.1. GCC Countries

            18.3.1.2. Turkey

            18.3.1.3. South Africa

            18.3.1.4. North Africa

            18.3.1.5. Rest of Middle East and Africa

        18.3.2. By Product

        18.3.3. By Application

        18.3.4. By End User

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Product

        18.4.3. By Application

        18.4.4. By End User

    18.5. Market Trends

    18.6. Key Market Participants - Intensity Mapping

    18.7. Drivers and Restraints - Impact Analysis

    18.8. Country Level Analysis & Forecast

        18.8.1. GCC Countries Market Analysis

            18.8.1.1. Introduction

            18.8.1.2. Market Analysis and Forecast by Market Taxonomy

                18.8.1.2.1. By Product

                18.8.1.2.2. By Application

                18.8.1.2.3. By End User

        18.8.2. Turkey Market Analysis

            18.8.2.1. Introduction

            18.8.2.2. Market Analysis and Forecast by Market Taxonomy

                18.8.2.2.1. By Product

                18.8.2.2.2. By Application

                18.8.2.2.3. By End User

        18.8.3. South Africa Market Analysis

            18.8.3.1. Introduction

            18.8.3.2. Market Analysis and Forecast by Market Taxonomy

                18.8.3.2.1. By Product

                18.8.3.2.2. By Application

                18.8.3.2.3. By End User

        18.8.4. North Africa Market Analysis

            18.8.4.1. Introduction

            18.8.4.2. Market Analysis and Forecast by Market Taxonomy

                18.8.4.2.1. By Product

                18.8.4.2.2. By Application

                18.8.4.2.3. By End User

19. Market Structure Analysis

    19.1. Market Analysis by Tier of Companies

    19.2. Market Share Analysis of Top Players

    19.3. Market Presence Analysis

20. Competition Analysis

    20.1. Competition Dashboard

    20.2. Competition Benchmarking

    20.3. Competition Deep Dive

        20.3.1. Agilent Technologies Inc.

            20.3.1.1. Overview

            20.3.1.2. Product Portfolio

            20.3.1.3. Profitability by Market Segments (Product/Channel/Region)

            20.3.1.4. Sales Footprint

            20.3.1.5. SWOT Analysis

            20.3.1.6. Key Financials

            20.3.1.7. Strategy Overview

        20.3.2. Genescript Biotech Corporation

            20.3.2.1. Overview

            20.3.2.2. Product Portfolio

            20.3.2.3. Profitability by Market Segments (Product/Channel/Region)

            20.3.2.4. Sales Footprint

            20.3.2.5. SWOT Analysis

            20.3.2.6. Key Financials

            20.3.2.7. Strategy Overview

        20.3.3. Bio-Rad Laboratories Inc

            20.3.3.1. Overview

            20.3.3.2. Product Portfolio

            20.3.3.3. Profitability by Market Segments (Product/Channel/Region)

            20.3.3.4. Sales Footprint

            20.3.3.5. SWOT Analysis

            20.3.3.6. Key Financials

            20.3.3.7. Strategy Overview

        20.3.4. Merck & Co Inc

            20.3.4.1. Overview

            20.3.4.2. Product Portfolio

            20.3.4.3. Profitability by Market Segments (Product/Channel/Region)

            20.3.4.4. Sales Footprint

            20.3.4.5. SWOT Analysis

            20.3.4.6. Key Financials

            20.3.4.7. Strategy Overview

        20.3.5. OriGene Technologies, Inc

            20.3.5.1. Overview

            20.3.5.2. Product Portfolio

            20.3.5.3. Profitability by Market Segments (Product/Channel/Region)

            20.3.5.4. Sales Footprint

            20.3.5.5. SWOT Analysis

            20.3.5.6. Key Financials

            20.3.5.7. Strategy Overview

        20.3.6. New England Biolabs Inc

            20.3.6.1. Overview

            20.3.6.2. Product Portfolio

            20.3.6.3. Profitability by Market Segments (Product/Channel/Region)

            20.3.6.4. Sales Footprint

            20.3.6.5. SWOT Analysis

            20.3.6.6. Key Financials

            20.3.6.7. Strategy Overview

        20.3.7. Illumina, Inc.

            20.3.7.1. Overview

            20.3.7.2. Product Portfolio

            20.3.7.3. Profitability by Market Segments (Product/Channel/Region)

            20.3.7.4. Sales Footprint

            20.3.7.5. SWOT Analysis

            20.3.7.6. Key Financials

            20.3.7.7. Strategy Overview

        20.3.8. Thermo Fisher Scientific, Inc.,

            20.3.8.1. Overview

            20.3.8.2. Product Portfolio

            20.3.8.3. Profitability by Market Segments (Product/Channel/Region)

            20.3.8.4. Sales Footprint

            20.3.8.5. SWOT Analysis

            20.3.8.6. Key Financials

            20.3.8.7. Strategy Overview

        20.3.9. QIAGEN N.V.,

            20.3.9.1. Overview

            20.3.9.2. Product Portfolio

            20.3.9.3. Profitability by Market Segments (Product/Channel/Region)

            20.3.9.4. Sales Footprint

            20.3.9.5. SWOT Analysis

            20.3.9.6. Key Financials

            20.3.9.7. Strategy Overview

        20.3.10. Zymo Research Corporation

            20.3.10.1. Overview

            20.3.10.2. Product Portfolio

            20.3.10.3. Profitability by Market Segments (Product/Channel/Region)

            20.3.10.4. Sales Footprint

            20.3.10.5. SWOT Analysis

            20.3.10.6. Key Financials

            20.3.10.7. Strategy Overview

        20.3.11. Promega Corporation

            20.3.11.1. Overview

            20.3.11.2. Product Portfolio

            20.3.11.3. Profitability by Market Segments (Product/Channel/Region)

            20.3.11.4. Sales Footprint

            20.3.11.5. SWOT Analysis

            20.3.11.6. Key Financials

            20.3.11.7. Strategy Overview

        20.3.12. HiMedia Laboratories

            20.3.12.1. Overview

            20.3.12.2. Product Portfolio

            20.3.12.3. Profitability by Market Segments (Product/Channel/Region)

            20.3.12.4. Sales Footprint

            20.3.12.5. SWOT Analysis

            20.3.12.6. Key Financials

            20.3.12.7. Strategy Overview

        20.3.13. Avantor, Inc.

            20.3.13.1. Overview

            20.3.13.2. Product Portfolio

            20.3.13.3. Profitability by Market Segments (Product/Channel/Region)

            20.3.13.4. Sales Footprint

            20.3.13.5. SWOT Analysis

            20.3.13.6. Key Financials

            20.3.13.7. Strategy Overview

        20.3.14. Scarab Genomics, LLC

            20.3.14.1. Overview

            20.3.14.2. Product Portfolio

            20.3.14.3. Profitability by Market Segments (Product/Channel/Region)

            20.3.14.4. Sales Footprint

            20.3.14.5. SWOT Analysis

            20.3.14.6. Key Financials

            20.3.14.7. Strategy Overview

        20.3.15. Lucigen

            20.3.15.1. Overview

            20.3.15.2. Product Portfolio

            20.3.15.3. Profitability by Market Segments (Product/Channel/Region)

            20.3.15.4. Sales Footprint

            20.3.15.5. SWOT Analysis

            20.3.15.6. Key Financials

            20.3.15.7. Strategy Overview

        20.3.16. Tonbo Biosciences

            20.3.16.1. Overview

            20.3.16.2. Product Portfolio

            20.3.16.3. Profitability by Market Segments (Product/Channel/Region)

            20.3.16.4. Sales Footprint

            20.3.16.5. SWOT Analysis

            20.3.16.6. Key Financials

            20.3.16.7. Strategy Overview

        20.3.17. Transgen Biotech

            20.3.17.1. Overview

            20.3.17.2. Product Portfolio

            20.3.17.3. Profitability by Market Segments (Product/Channel/Region)

            20.3.17.4. Sales Footprint

            20.3.17.5. SWOT Analysis

            20.3.17.6. Key Financials

            20.3.17.7. Strategy Overview

        20.3.18. Codex DNA, Inc.

            20.3.18.1. Overview

            20.3.18.2. Product Portfolio

            20.3.18.3. Profitability by Market Segments (Product/Channel/Region)

            20.3.18.4. Sales Footprint

            20.3.18.5. SWOT Analysis

            20.3.18.6. Key Financials

            20.3.18.7. Strategy Overview

        20.3.19. bluebird bio, Inc.

            20.3.19.1. Overview

            20.3.19.2. Product Portfolio

            20.3.19.3. Profitability by Market Segments (Product/Channel/Region)

            20.3.19.4. Sales Footprint

            20.3.19.5. SWOT Analysis

            20.3.19.6. Key Financials

            20.3.19.7. Strategy Overview

21. Assumptions and Acronyms Used

22. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Market Analysis 2017–2021 and Forecast 2022–2032, by Product

Table 02: Global Market Analysis 2017–2021 and Forecast 2022–2032by Application

Table 03: Global Market Analysis 2017–2021 and Forecast 2022–2032, by End User

Table 04: Global Market Analysis 2017–2021 and Forecast 2022–2032, by Region

Table 05: North America Market Value (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Country

Table 06: North America Market Value (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Product

Table 07: North America Market Value (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Application

Table 08: North America Market Value (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by End User

Table 09: Latin America Market Value (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Country

Table 10: Latin America Market Value (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Product

Table 11: Latin America Market Value (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Application

Table 12: Latin America Market Value (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by End User

Table 13: Europe Market Value (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Country

Table 14: Europe Market Value (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Product

Table 15: Europe Market Analysis 2017–2021 and Forecast 2022–2032by Application

Table 16: Europe Market Value (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by End User

Table 17: East Asia Market Value (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Country

Table 18: East Asia Market Value (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Product

Table 19: East Asia Market Value (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Application

Table 20: East Asia Market Value (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by End User

Table 21: South Asia Market Value (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Country

Table 22: South Asia Market Value (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Product

Table 23: South Asia Market Value (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Application

Table 24: South Asia Market Value (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by End User

Table 25: Oceania Market Value (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Country

Table 26: Oceania Market Value (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Product

Table 27: Oceania Market Analysis 2017–2021 and Forecast 2022–2032by Application

Table 28: Oceania Market Value (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by End User

Table 29: Middle East & Africa Market Value (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Country

Table 30: Middle East & Africa Market Value (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Product

Table 31: Middle East & Africa Market Analysis 2017–2021 and Forecast 2022–2032by Application

Table 32: Middle East & Africa Market Value (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by End User

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Market Value (US$ Mn) Analysis, 2017–2021

Figure 02: ;Global Market Forecast & Y-o-Y Growth, 2022–2032

Figure 03: Global Market Absolute $ Opportunity (US$ Mn) Analysis, 2022-2032

Figure 04: Global Market Value Share (%) Analysis 2022 and 2032, by Product

Figure 05: Global Market Y-o-Y Growth (%) Analysis 2022-2032, by Product

Figure 06: Global Market Attractiveness Analysis 2022–2032, by Product

Figure 07: Global Market Value Share (%) Analysis 2022 and 2032, by Application

Figure 08: Global Market Y-o-Y Growth (%) Analysis 2022-2032, by Application

Figure 09: Global Market Attractiveness Analysis 2022–2032, by Application

Figure 10: Global Market Value Share (%) Analysis 2022 and 2032, by End User

Figure 11: Global Market Y-o-Y Growth (%) Analysis 2022-2032, by End User

Figure 12: Global Market Attractiveness Analysis 2022–2032, by End User

Figure 13: Global Market Value Share (%) Analysis 2022 and 2032, by Region

Figure 14: Global Market Y-o-Y Growth (%) Analysis 2022-2032, by Region

Figure 15: Global Market Attractiveness Analysis 2022–2032, by Region

Figure 16: North America Market Value (US$ Mn) Analysis, 2017–2021

Figure 17: North America Market Value (US$ Mn) Forecast, 2022-2032

Figure 18: North America Market Value Share, by Product (2022 E)

Figure 19: North America Market Value Share, by Application (2022 E)

Figure 20: North America Market Value Share, by End User (2022 E)

Figure 21: North America Market Value Share, by Country (2022 E)

Figure 22: North America Market Attractiveness Analysis by Product, 2022–2032

Figure 23: North America Market Attractiveness Analysis by Application, 2022–2032

Figure 24: North America Market Attractiveness Analysis by End User, 2022–2032

Figure 25: North America Market Attractiveness Analysis by Country, 2022–2032

Figure 26: U.S. Market Value Proportion Analysis, 2021

Figure 27: Global Vs. U.S. Growth Comparison

Figure 28: U.S. Market Share Analysis (%) by Product, 2021 & 2032

Figure 29: U.S. Market Share Analysis (%) by Application, 2021 & 2032

Figure 30: U.S. Market Share Analysis (%) by End User, 2021 & 2032

Figure 31: Canada Market Value Proportion Analysis, 2021

Figure 32: Global Vs. Canada. Growth Comparison

Figure 33: Canada Market Share Analysis (%) by Product, 2021 & 2032

Figure 34: Canada Market Share Analysis (%) by Application, 2021 & 2032

Figure 35: Canada Market Share Analysis (%) by End User, 2021 & 2032

Figure 36: Latin America Market Value (US$ Mn) Analysis, 2017–2021

Figure 37: Latin America Market Value (US$ Mn) Forecast, 2022-2032

Figure 38: Latin America Market Value Share, by Product (2022 E)

Figure 39: Latin America Market Value Share, by Application (2022 E)

Figure 40: Latin America Market Value Share, by End User (2022 E)

Figure 41: Latin America Market Value Share, by Country (2022 E)

Figure 42: Latin America Market Attractiveness Analysis by Product, 2022–2032

Figure 43: Latin America Market Attractiveness Analysis by Application, 2022–2032

Figure 44: Latin America Market Attractiveness Analysis by End User, 2022–2032

Figure 45: Latin America Market Attractiveness Analysis by Country, 2022–2032

Figure 46: Mexico Market Value Proportion Analysis, 2021

Figure 47: Global Vs Mexico Growth Comparison

Figure 48: Mexico Market Share Analysis (%) by Product, 2021 & 2032

Figure 49: Mexico Market Share Analysis (%) by Application, 2021 & 2032

Figure 50: Mexico Market Share Analysis (%) by End User, 2021 & 2032

Figure 51: Brazil Market Value Proportion Analysis, 2021

Figure 52: Global Vs. Brazil. Growth Comparison

Figure 53: Brazil Market Share Analysis (%) by Product, 2021 & 2032

Figure 54: Brazil Market Share Analysis (%) by Application, 2021 & 2032

Figure 55: Brazil Market Share Analysis (%) by End User, 2021 & 2032

Figure 56: Argentina Market Value Proportion Analysis, 2021

Figure 57: Global Vs Argentina Growth Comparison

Figure 58: Argentina Market Share Analysis (%) by Product, 2021 & 2032

Figure 59: Argentina Market Share Analysis (%) by Application, 2021 & 2032

Figure 60: Argentina Market Share Analysis (%) by End User, 2021 & 2032

Figure 61: Europe Market Value (US$ Mn) Analysis, 2017–2021

Figure 62: Europe Market Value (US$ Mn) Forecast, 2022-2032

Figure 63: Europe Market Value Share, by Product (2022 E)

Figure 64: Europe Market Value Share, by Application (2022 E)

Figure 65: Europe Market Value Share, by End User (2022 E)

Figure 66: Europe Market Value Share, by Country (2022 E)

Figure 67: Europe Market Attractiveness Analysis by Product, 2022–2032

Figure 68: Europe Market Attractiveness Analysis by Application, 2022–2032

Figure 69: Europe Market Attractiveness Analysis by End User, 2022–2032

Figure 70: Europe Market Attractiveness Analysis by Country, 2022–2032

Figure 71: UK Market Value Proportion Analysis, 2021

Figure 72: Global Vs. UK Growth Comparison

Figure 73: UK Market Share Analysis (%) by Product, 2021 & 2032

Figure 74: UK Market Share Analysis (%) by Application, 2021 & 2032

Figure 75: UK Market Share Analysis (%) by End User, 2021 & 2032

Figure 76: Germany Market Value Proportion Analysis, 2021

Figure 77: Global Vs. Germany Growth Comparison

Figure 78: Germany Market Share Analysis (%) by Product, 2021 & 2032

Figure 79: Germany Market Share Analysis (%) by Application, 2021 & 2032

Figure 80: Germany Market Share Analysis (%) by End User, 2021 & 2032

Figure 81: Italy Market Value Proportion Analysis, 2021

Figure 82: Global Vs. Italy Growth Comparison

Figure 83: Italy Market Share Analysis (%) by Product, 2021 & 2032

Figure 84: Italy Market Share Analysis (%) by Application, 2021 & 2032

Figure 85: Italy Market Share Analysis (%) by End User, 2021 & 2032

Figure 86: France Market Value Proportion Analysis, 2021

Figure 87: Global Vs France Growth Comparison

Figure 88: France Market Share Analysis (%) by Product, 2021 & 2032

Figure 89: France Market Share Analysis (%) by Application, 2021 & 2032

Figure 90: France Market Share Analysis (%) by End User, 2021 & 2032

Figure 91: Spain Market Value Proportion Analysis, 2021

Figure 92: Global Vs Spain Growth Comparison

Figure 93: Spain Market Share Analysis (%) by Product, 2021 & 2032

Figure 94: Spain Market Share Analysis (%) by Application, 2021 & 2032

Figure 95: Spain Market Share Analysis (%) by End User, 2021 & 2032

Figure 96: Russia Market Value Proportion Analysis, 2021

Figure 97: Global Vs Russia Growth Comparison

Figure 98: Russia Market Share Analysis (%) by Product, 2021 & 2032

Figure 99: Russia Market Share Analysis (%) by Application, 2021 & 2032

Figure 100: Russia Market Share Analysis (%) by End User, 2021 & 2032

Figure 101: BENELUX Market Value Proportion Analysis, 2021

Figure 102: Global Vs BENELUX Growth Comparison

Figure 103: BENELUX Market Share Analysis (%) by Product, 2021 & 2032

Figure 104: BENELUX Market Share Analysis (%) by Application, 2021 & 2032

Figure 105: BENELUX Market Share Analysis (%) by End User, 2021 & 2032

Figure 106: East Asia Market Value (US$ Mn) Analysis, 2017–2021

Figure 107: East Asia Market Value (US$ Mn) Forecast, 2022-2032

Figure 108: East Asia Market Value Share, by Product (2022 E)

Figure 109: East Asia Market Value Share, by Application (2022 E)

Figure 110: East Asia Market Value Share, by End User (2022 E)

Figure 111: East Asia Market Value Share, by Country (2022 E)

Figure 112: East Asia Market Attractiveness Analysis by Product, 2022–2032

Figure 113: East Asia Market Attractiveness Analysis by Application, 2022–2032

Figure 114: East Asia Market Attractiveness Analysis by End User, 2022–2032

Figure 115: East Asia Market Attractiveness Analysis by Country, 2022–2032

Figure 116: China Market Value Proportion Analysis, 2021

Figure 117: Global Vs. China Growth Comparison

Figure 118: China Market Share Analysis (%) by Product, 2021 & 2032

Figure 119: China Market Share Analysis (%) by Application, 2021 & 2032

Figure 120: China Market Share Analysis (%) by End User, 2021 & 2032

Figure 121: Japan Market Value Proportion Analysis, 2021

Figure 122: Global Vs. Japan Growth Comparison

Figure 123: Japan Market Share Analysis (%) by Product, 2021 & 2032

Figure 124: Japan Market Share Analysis (%) by Application, 2021 & 2032

Figure 125: Japan Market Share Analysis (%) by End User, 2021 & 2032

Figure 126: South Korea Market Value Proportion Analysis, 2021

Figure 127: Global Vs South Korea Growth Comparison

Figure 128: South Korea Market Share Analysis (%) by Product, 2021 & 2032

Figure 129: South Korea Market Share Analysis (%) by Application, 2021 & 2032

Figure 130: South Korea Market Share Analysis (%) by End User, 2021 & 2032

Figure 131: South Asia Market Value (US$ Mn) Analysis, 2017–2021

Figure 132: South Asia Market Value (US$ Mn) Forecast, 2022-2032

Figure 133: South Asia Market Value Share, by Product (2022 E)

Figure 134: South Asia Market Value Share, by Application (2022 E)

Figure 135: South Asia Market Value Share, by End User (2022 E)

Figure 136: South Asia Market Value Share, by Country (2022 E)

Figure 137: South Asia Market Attractiveness Analysis by Product, 2022–2032

Figure 138: South Asia Market Attractiveness Analysis by Application, 2022–2032

Figure 139: South Asia Market Attractiveness Analysis by End User, 2022–2032

Figure 140: South Asia Market Attractiveness Analysis by Country, 2022–2032

Figure 141: India Market Value Proportion Analysis, 2021

Figure 142: Global Vs. India Growth Comparison

Figure 143: India Market Share Analysis (%) by Product, 2021 & 2032

Figure 144: India Market Share Analysis (%) by Application, 2021 & 2032

Figure 145: India Market Share Analysis (%) by End User, 2021 & 2032

Figure 146: Indonesia Market Value Proportion Analysis, 2021

Figure 147: Global Vs. Indonesia Growth Comparison

Figure 148: Indonesia Market Share Analysis (%) by Product, 2021 & 2032

Figure 149: Indonesia Market Share Analysis (%) by Application, 2021 & 2032

Figure 150: Indonesia Market Share Analysis (%) by End User, 2021 & 2032

Figure 151: Malaysia Market Value Proportion Analysis, 2021

Figure 152: Global Vs. Malaysia Growth Comparison

Figure 153: Malaysia Market Share Analysis (%) by Product, 2021 & 2032

Figure 154: Malaysia Market Share Analysis (%) by Application, 2021 & 2032

Figure 155: Malaysia Market Share Analysis (%) by End User, 2021 & 2032

Figure 156: Thailand Market Value Proportion Analysis, 2021

Figure 157: Global Vs. Thailand Growth Comparison

Figure 158: Thailand Market Share Analysis (%) by Product, 2021 & 2032

Figure 159: Thailand Market Share Analysis (%) by Application, 2021 & 2032

Figure 160: Thailand Market Share Analysis (%) by End User, 2021 & 2032

Figure 161: Oceania Market Value (US$ Mn) Analysis, 2017–2021

Figure 162: Oceania Market Value (US$ Mn) Forecast, 2022-2032

Figure 163: Oceania Market Value Share, by Product (2022 E)

Figure 164: Oceania Market Value Share, by Application (2022 E)

Figure 165: Oceania Market Value Share, by End User (2022 E)

Figure 166: Oceania Market Value Share, by Country (2022 E)

Figure 167: Oceania Market Attractiveness Analysis by Product, 2022–2032

Figure 168: Oceania Market Attractiveness Analysis by Application, 2022–2032

Figure 169: Oceania Market Attractiveness Analysis by End User, 2022–2032

Figure 170: Oceania Market Attractiveness Analysis by Country, 2022–2032

Figure 171: Australia Market Value Proportion Analysis, 2021

Figure 172: Global Vs. Australia Growth Comparison

Figure 173: Australia Market Share Analysis (%) by Product, 2021 & 2032

Figure 174: Australia Market Share Analysis (%) by Application, 2021 & 2032

Figure 175: Australia Market Share Analysis (%) by End User, 2021 & 2032

Figure 176: New Zealand Market Value Proportion Analysis, 2021

Figure 177: Global Vs New Zealand Growth Comparison

Figure 178: New Zealand Market Share Analysis (%) by Product, 2021 & 2032

Figure 179: New Zealand Market Share Analysis (%) by Application, 2021 & 2032

Figure 180: New Zealand Market Share Analysis (%) by End User, 2021 & 2032

Figure 181: Middle East & Africa Market Value (US$ Mn) Analysis, 2017–2021

Figure 182: Middle East & Africa Market Value (US$ Mn) Forecast, 2022-2032

Figure 183: Middle East & Africa Market Value Share, by Product (2022 E)

Figure 184: Middle East & Africa Market Value Share, by Application (2022 E)

Figure 185: Middle East & Africa Market Value Share, by End User (2022 E)

Figure 186: Middle East & Africa Market Value Share, by Country (2022 E)

Figure 187: Middle East & Africa Market Attractiveness Analysis by Product, 2022–2032

Figure 188: Middle East & Africa Market Attractiveness Analysis by Application, 2022–2032

Figure 189: Middle East & Africa Market Attractiveness Analysis by End User, 2022–2032

Figure 190: Middle East & Africa Market Attractiveness Analysis by Country, 2022–2032

Figure 191: GCC Countries Market Value Proportion Analysis, 2021

Figure 192: Global Vs GCC Countries Growth Comparison

Figure 193: GCC Countries Market Share Analysis (%) by Product, 2021 & 2032

Figure 194: GCC Countries Market Share Analysis (%) by Application, 2021 & 2032

Figure 195: GCC Countries Market Share Analysis (%) by End User, 2021 & 2032

Figure 196: Turkey Market Value Proportion Analysis, 2021

Figure 197: Global Vs. Turkey Growth Comparison

Figure 198: Turkey Market Share Analysis (%) by Product, 2021 & 2032

Figure 199: Turkey Market Share Analysis (%) by Application, 2021 & 2032

Figure 200: Turkey Market Share Analysis (%) by End User, 2021 & 2032

Figure 201: South Africa Market Value Proportion Analysis, 2021

Figure 202: Global Vs. South Africa Growth Comparison

Figure 203: South Africa Market Share Analysis (%) by Product, 2021 & 2032

Figure 204: South Africa Market Share Analysis (%) by Application, 2021 & 2032

Figure 205: South Africa Market Share Analysis (%) by End User, 2021 & 2032

Figure 206: North Africa Market Value Proportion Analysis, 2021

Figure 207: Global Vs North Africa Growth Comparison

Figure 208: North Africa Market Share Analysis (%) by Product, 2021 & 2032

Figure 209: North Africa Market Share Analysis (%) by Application, 2021 & 2032

Figure 210: North Africa Market Share Analysis (%) by End User, 2021 & 2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Long-Acting Monoclonal Antibodies Market

Published : October 2021

Healthcare

Gene Editing Tools Market

Published : February 2022

Healthcare

Recombinant Vaccines Market

Published : November 2018

Healthcare

Gene Synthesis Market

Published : February 2022

Google translate

Competent Cells Market